R&D Scientists and algorithms: Finding the right balance in mode... The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
Views & Analysis Expanding data sources: faster drug development? Using advanced technology and the skills of the data scientist to manage data from diverse sources.
News Aicuris acquisition delivers new drug for Asahi Kasei Asahi Kasei's $920m takeover of Germany's Aicuris in April has paid off with FDA approval for the herpes simplex virus drug at the heart of the deal.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
